Vanguard Diagnostics ’s Post

Dr. NEERAJ JAIN, Founder President, Medical Education & Learning Point (MELAP), Organizing Chairman, PATHCON, discusses procurement planning in hematology labs in the latest edition of Medical Buyer. For complete perspective: https://lnkd.in/giDh3yts #hematology #labs #planning #resources #development #institutions #laboratory #reagents #screening #diagnosis #monitoring #research #quality #assurance #testing

✨ New Systematic Review Alert from the Journal of Advanced Research in Medical and Health Science (ISSN: 2208-2425) ✨ 📢 "Comparison Diagnostic Accuracy of Ultrasonography Elastography for Detecting Liver Fibrosis Compared to Liver Biopsy: A Comprehensive Systematic Review and Meta-Analysis". research paper by Arwan Firmansyah, Arya Utama, YARSI University 🔍 Which diagnostic method holds the edge? This study dives deep into a systematic review and meta-analysis, comparing ultrasonography elastography against the gold-standard liver biopsy for detecting liver fibrosis. The research presents a critical evaluation of both techniques, highlighting the potential of non-invasive approaches to revolutionize clinical diagnostics. 🔑 Keywords: #UltrasonographyElastography #LiverFibrosis #LiverBiopsy 💡 Why this matters: Provides valuable insights for clinicians and researchers in hepatology. Evaluates diagnostic precision to enhance patient care. Promotes non-invasive alternatives in medical diagnostics. 🔗 Read the full article and explore more: https://lnkd.in/gB8TYMED Stay updated with the latest breakthroughs in medical science! Follow us for more cutting-edge research and developments in healthcare. 🚀 #MedicalResearch #Hepatology #Diagnostics #SystematicReview #HealthcareInnovation #OpenAccess #ResearchImpact

🔬 Uncover the complexities of this unique case and its implications for treatment. Read the new published case report in our journal Medical Sciences MDPI titled "Double Hit of Hydroxichloroquine and Amiodarone Induced Renal Phospholipidosis in a Patient with Monoclonal Gammopathy and Sclerodermiform Syndrome: A Case Report and Review of the Literature". 👥 Authors: De la Flor, J. C. et al. 🔗 Read the article here: https://lnkd.in/dBG-XQJY #MedicalResearch #CaseReport #Hydroxychloroquine #Amiodarone

PFA atrial fibrillation ablation, using the pentaspline PFA catheter (Farawave, Farapulse-Boston Scientific , is SAFE! The results of MANIFEST-17K study, recently published in Nature Medicine, are indeed very impressive. The co-authors should be congratulated for tediously pooling together retrospective real-world data from 106 centers in 20 countries regarding 17,642 treated patients. This is clearly the largest PFA study so far. We need however to wait cautiously for long-term clinical outcome in order to be convinced that we’re positively benefiting the patients. https://lnkd.in/dszec8yq

"Publication in International Journal of Research and Analytical Reviews (IJRAR)" "I am delighted to share that my project titled 'Pattern of Use of SGLT2 Inhibitors In Patient With Chronic Heart Failure In A Tertiary Care Hospital In South India 2021-22' has been published in the International Journal of Research and Analytical Reviews (IJRAR), Volume 10, Issue 2. This project was a Prospective Observational study conducted at the Krishna Institute of Medical Sciences (KIMS) hospital in Secunderabad, India, with a sample size of 103 adult patients. The study aimed to assess the efficacy, safety, and tolerability of SGLT2 inhibitors in chronic heart failure, as well as their impact on patient symptoms and quality of life. The key findings of the study included: 1. SGLT2 inhibitors, such as empagliflozin and dapagliflozin, showed positive results in heart failure management, with an improvement in ejection fraction observed during the study. 2. The chances of adverse effects like urinary tract infections, urogenital infections, and nausea occurring were low. 3. The study concluded that heart failure patients, regardless of their diabetes status, can be prescribed SGLT2 inhibitors. This project was a joint effort with my classmate soma shekar, conducted during our #Pharm.D. studies. It has provided us the valuable insights into the use of SGLT2 inhibitors in the Indian population, contributing to the existing body of knowledge in this field. #PharmD #Doctorofpharmacy #ClinicalResearch #Project #SGLT2Inhibitors #Publications

There are wide ranges of homoeopathic medicine for menorrhagia but lesser known medicine selected on the basis of uncommon, peculiar, rare symptoms. Lesser known medicine which is not used in day to day clinical practice because this medicine had few symptoms recorded through drug proving. This medicine is indicated towards a few specific conditions. Many homoeopaths in our fraternity are not aware of this lesser known medicine due to lack in literature and clinical use 1 . This study is to search for lesser known medicine as present our materia medica. by Dr. Munjal Thakkar | Dr. Divya Gamit "Efficacy of Lesser Known Homoeopathic Medicine in the Treatment of Menorrhagia: A Case Report of Aletris Farinosa" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-7 | Issue-6 , December 2023, URL: https://lnkd.in/dcWTs-2K Paper Url: https://lnkd.in/dRKChqyw

#Review Recent Advances in Biosensor Technologies for Point-of-Care Urinalysis by Chuljin Hwang, et al. https://lnkd.in/eqPMvEPM MDPI Ajou University #urinesensor #pointofcareurinalysis #clinicalapplication #dipsticktest #biosensors #openaccess #Abstract Human urine samples are non-invasive, readily available, and contain several components that can provide useful indicators of the health status of patients. Hence, urine is a desirable and important template to aid in the diagnosis of common clinical conditions. Conventional methods such as dipstick tests, urine culture, and urine microscopy are commonly used for urinalysis. Among them, the dipstick test is undoubtedly the most popular owing to its ease of use, low cost, and quick response. Despite these advantages, the dipstick test has limitations in terms of sensitivity, selectivity, reusability, and quantitative evaluation of diseases. Various biosensor technologies give it the potential for being developed into point-of-care (POC) applications by overcoming these limitations of the dipstick test. Here, we present a review of the biosensor technologies available to identify urine-based biomarkers that are typically detected by the dipstick test and discuss the present limitations and challenges that future development for their translation into POC applications for urinalysis.

Academics and healthcare professionals in Medicine, keeping abreast of the latest guidelines in hypertension therapy is crucial for both teaching and clinical practice. With Bionl.ai's advanced general search feature, accessing the most recent updates and comprehensive reviews on hypertension management has never been easier. #Bionlai | #Bioinformatics | #LiteratureReview | #PDFanalysis | #CancerResearch | #PubMed | #BioMedicine | #Research | #Hypertension | #HypertensionAwareness | #AcademicMedicine | #ClinicalPractice | #UptoDate

Our answer to hamas and all radical islam terror is scientific medical research 🚀 We're thrilled to announce a groundbreaking milestone in diabetes treatment! As the Director of Medical Affairs at Kadimastem, I'm proud to share our FDA INTERACT submission for Isletrx, an innovative therapy derived from embryonic stem cells, in collaboration with our fantastic partners at iTolerance. 🤝🔬 📣 In an inspiring Zoom meeting with iTolerance, led by the visionary CEO Anthony, we discussed not only our shared scientific goals but also the enduring spirit of collaboration and support. Anthony's heartfelt message of solidarity with Israel and his admiration for our resilience in these challenging times was deeply moving. 💪🇮🇱 👩⚕️ As director of medical affairs, I shared my belief in the power of medical excellence and innovation. Israel, with its rich history of medical breakthroughs, continues to be a global leader in healthcare advancements. At Kadimastem, we're committed to this legacy, by my dad 👨 Michel Revel,MD PHD, contributing to medical progress worldwide and leading the way in life-changing therapies. 🌍✨ 🛡️ Against all odds, our determination remains unshaken. We believe in turning challenges into opportunities for healing. Rooted in Jewish values, tikun olam, תיקוּן עולם we're driven to repair and improve the world, a mission that no adversary can halt. This FDA INTERACT submission is a testament to our unwavering commitment to bettering lives. 🌟 🙌 Together with iTolerance, we're not just pushing the boundaries of medicine; we're creating a future filled with hope and health for diabetes patients across the globe. Join us on this incredible journey! 🌈💖 #DiabetesCure 🚑 #Kadimastem💡 #iTolerance 🤝 #MedicalInnovation 🌟 #IsraelStrong 🇮🇱 #FDA 📜 #Isletrx 🌱 #TogetherWeCan 🌍

🎉 Exciting News! Our groundbreaking study on knee osteoarthritis management has been published! 🦵💉 https://lnkd.in/dcNekZNC I'm thrilled to share that our research comparing isometric quadriceps training, glucosamine, and chondroitin sulphate iontophoresis for knee osteoarthritis has been published in the European Journal of Medical and Health Research. As one of the authors, I'm particularly proud of how this study advances the field of pharmacophysiotherapy - an innovative subspecialty combining pharmacology and physiotherapy techniques. This approach holds immense potential for enhancing patient outcomes and reducing healthcare costs. Some key findings: • All three interventions significantly reduced pain and improved function • Quadriceps strengthening showed the highest efficacy overall • Iontophoresis delivery of glucosamine and chondroitin proved effective This research exemplifies how we can leverage interdisciplinary approaches to tackle complex health challenges. I'm excited to continue exploring how pharmacophysiotherapy can contribute to public health and health economics. Huge thanks to my brilliant co-authors: K. Lasisi, Prof. Ayodele Onigbinde, S.C. Ayinla , O.E. Ayeni, T.F. Kekere, Adedayo Awotipe, Adedayo Borode, T. Ayodeji Ayobanji, T. Adeyemi, Ibitoye Adebukola, Azeezat Ajao, Dr Anelechi Kenneth Madume BSc PT., M.Ed., PhD, and Chinonso Ugwu. Your expertise and dedication made this possible! Who's ready to revolutionize osteoarthritis care? This study is just the beginning! 💪🔬 #PharmacophysiotherapyInnovation #OsteoarthritisResearch #HealthEconomics #PhysiotherapyAdvancement